Homeopathic Remedy Prescription Note

Date/Time: [Date and time note created]

Effective Date: [Remedy start date if different from documentation date]

Patient: [Name and identifiers per organization policy]

Encounter Type: [in-person / telehealth / phone / patient portal message]

Author: [Clinician name and credentials]

Indication & Clinical Context

(Format as 2–4 concise bullet points or a short paragraph. For pure refills with no changes, may simply reference where the indication is documented elsewhere.)

• Primary indication: [Symptom or diagnosis; include laterality/location if relevant]
• Severity/acuity: [Severity and course/onset]
• Patient preference/goal: [Decision drivers] (Include only if it informed the decision)
• Red flags assessed: [Brief negative screen or actions taken] (Include only if relevant to ruling out serious conditions)

Remedy Order

(Create one order block per remedy. Use clear, unambiguous wording; never use error-prone abbreviations such as QD, QOD, U, or IU.)

• Remedy: [Full product name as labeled, including Latin/homeopathic name]
• Potency: [e.g., 6X, 30C, 200K]
• Form: [pellets / liquid / ointment / other]
• Route: [oral / sublingual / topical] (Specify site for topical)
• Manufacturer/Brand: [Brand/manufacturer if known]
• Excipients: [lactose / sucrose / alcohol base / see label] (Note if relevant to allergy risk)
• Directions:
  • Dose: [Number of pellets / drops / mL / application amount]
  • Frequency: [Use plain language: once daily, twice daily, every 8 hours]
  • Administration instructions: [Special guidance for safe use]
  • PRN use: [Triggering symptom and maximum frequency] (Include only if PRN)
• Timing & Safety:
  • Start Date: [Start date]
  • Duration or Review Date: [Duration or date to reassess]
  • Stop Criteria: [Clinical endpoint for stopping, e.g., "stop when symptoms resolved for 48 hours"]
  • Safety Stop: [Conditions requiring immediate discontinuation and clinic contact, e.g., rash, swelling, breathing difficulty, worsening symptoms]
  • Escalation: [Timeframe and instructions if no improvement]

(Repeat the above order block for each additional remedy.)

Safety Screening

• Allergies Reviewed: [Yes / No / Unknown] — [Relevant findings] (If not documented, insert "[Not documented]")
• Excipient Sensitivities: [Lactose / sucrose / alcohol / topical carrier / None identified] (If not documented, insert "[Not documented]")
• Medication List Reviewed: [Yes / No] — [Date] — [Pertinent items including prescription meds, OTCs, supplements, other homeopathic remedies; note interactions or state none identified] (If not reviewed, document reason. If not documented, insert "[Not documented]")
• Population-specific screening: (Mark N/A for categories that do not apply)
  • Pregnancy/Lactation: [Status and relevant considerations / N/A]
  • Pediatric: [Caregiver administration plan and dosing safeguards / N/A]
  • Older adult: [Cognitive/functional status, fall risk, polypharmacy considerations / N/A]

Counseling & Informed Consent

(Document only if counseling discussion occurred; do not generate generic counseling language unless confirmed in dictation.)

• Discussion covered: [Topics addressed: nature/purpose of remedy, expected benefits, material risks including adverse reactions, product quality variability, alternatives including conventional treatment and watchful waiting]
• Regulatory status disclosure: Patient informed that homeopathic products are not FDA-approved for safety or effectiveness and that scientific evidence for efficacy may be limited. (Include only if this disclosure was provided)
• Patient decision: [Accepted / Declined / Deferred] — [Rationale if provided]
• Understanding confirmed: [Teach-back used / Patient verbalized understanding / Other method]
• Agreement to plan: [Yes / No] — [Escalation criteria acknowledged]

Monitoring & Follow-up

• What to monitor: [Target symptoms, frequency/severity, adverse effects to watch for]
• Follow-up: [Timing and modality: in-person / telehealth / phone / portal message]
• Reporting instructions: [How to report adverse events or concerns; after-hours contact if relevant]
• Concurrent conventional therapy: [Plan for coordination / N/A]

Dispensing Details

(Include only if the clinic dispenses the remedy or procurement details are clinically important; omit this section entirely if no dispensing or procurement information is provided.)

• Source: [Clinic-dispensed / Patient to purchase OTC / Sent to pharmacy]
• Quantity: [Amount] — Refills: [Number / None]
• Lot #: [Lot number] — Expiration: [Date] (Clinic-dispensed only)
• Product identification for OTC purchase: [Brand, potency, form, size, distinguishing features to prevent mix-ups] (If applicable)
• Storage instructions: [Relevant guidance if clinically important]

Signature

Clinician Electronic Signature: [Name, credentials, date/time]

(If documentation was prepared by scribe or transcription, include attestation: "This documentation was prepared by [scribe name/role] and reviewed and authenticated by the authoring clinician.")